Anyone who’s worked around clinical trials knows the problem isn’t a lack of data on risk; it’s that the data usually lives in a dozen different spreadsheets, none of which talk to each other. Risk registers get updated in one place, oversight decisions get logged somewhere else, and by the time an inspection rolls around, piecing together a clear, traceable story of how risk was actually managed can turn into a scramble.
Sound familiar? It’s this exact scenario that led to the creation of Qlarix. Its WiseCLIN platform solves exactly this problem. It is quickly becoming one of the more interesting names in Risk-Based Quality Management.
Want to know more? Let’s take a look.
Who Are Qlarix
Qlarix is the company behind WiseCLIN. It is a purpose-built Risk-Based Quality Management (RBQM) platform designed specifically for clinical trial sponsors and CROs. The team behind the platform brings a varied skill set to the table.
John Michaloudis holds a background in commerce and accounting alongside 20+ years in finance and is a Microsoft Excel MVP.
Leire Zúñiga has a PharmD and PhD with over 20 years across pharma, biotech, and CROs, skilled in quality management, Good Clinical Practice, and computerized system validation.
Mateo Gómez is an industrial engineer with an MBA and 35+ years developing and implementing technological solutions.
That combination of clinical quality expertise and technical development experience shows up clearly in how WiseCLIN is put together.
What WiseCLIN Actually Does
At its core, WiseCLIN connects Critical to Quality factors, risk, controls, Key Risk Indicators, Quality Tolerance Limits, review cycles, and oversight decisions into a single traceable workflow. Rather than sponsors and CROs juggling disconnected spreadsheets and static risk registers, WiseCLIN centralizes all of it, giving the team one place to identify the critical areas that could put a trial at risk from patient safety and data reliability through to vendor performance, site conduct and regulatory acceptance.
Those risks are then translated into a proportionate oversight strategy focused on where action matters rather than spreading attention evenly across every possible risk regardless of severity. That’s a meaningfully different approach to platforms that focus mainly on risk-based monitoring since WiseCLIN is built to support the broader RBQM picture rather than just one piece of it.
Built Around Real Compliance Regulations
WiseCLIN’s workflows are aligned with ICH E6 and E8, and the platform is built to meet global requirements including ICH E6(R3), ICH E8(R1) and ICH Q9 standards. That’s a significant detail given how much regulatory pressure is currently being placed on sponsors and CROs to demonstrate consistent risk-based oversight rather than reactive quality management. According to Qlarix, WiseCLIN helps teams achieve compliance with the latest ICH E6(R3) requirements without the usual complexity that comes with it.
Feature Set
WiseCLIN’s feature list reflects just how much of the RBQM lifecycle it’s designed to cover. This includes Dynamic Risk Management Boards, which are tailored to study complexity. There is centralized oversight where you can get real-time data visualization and a customizable dashboard for tracking both progress and compliance.
There’s also a configurable Critical to Quality factors schema built on Clinical Trial Transformation Initiative recommendations alongside configurable risk scoring model that can be tailored to an organization’s own risk tolerance.
You also get an action management module that defines, assigns, and tracks risk control actions using integrated RACI matrices so ownership stays clear throughout a trial. The platform also integrates with existing systems like CTMS, eTMF and EDC, meaning it’s designed to sit alongside a sponsor’s existing tech stack rather than requiring a wholesale switch. On top of that, WiseCLIN uses AI to draw on an organizations accumulated lessons, feeding that intelligence back into future risk management strategies.
The Numbers Qlarix Points To
According to Qlarix, organizations using WiseCLIN can reduce trial risks by 30% or more and cut trial costs by up to 20% while saving hundreds of hours that would otherwise go into manual quality oversight. Anyone in the industry will know these are some significant claims, especially as budget overruns and compliance failures carry real consequences.
This positions WiseCLIN not as a nice dashboard but an actual beneficial operational upgrade. When it comes to sponsors and CROs, the time saved on manual oversight alone when managing multiple trials at once can free up teams to focus on the risks that genuinely need human judgment rather than getting buried in routine tracking and reporting.
Support Beyond the Software
Here’s a really important piece of information. Qlarix doesn’t just hand over the platform and leave the team to figure it out. The company works closely with its sister business, Pharmity, which provides consulting and training services drawing on decades of experience in clinical quality management. This partnership means that organizations adopting WiseCLIN aren’t just getting software but also the expertise to actually embed a risk-based quality culture across their trials, with consultants available to support teams until they reach full independence in managing RBQM themselves.
It’s this type of hands-on guidance that’s invaluable to new users or those new to formal RBQM processes, and it can make the difference between software that sits half used and one that genuinely shapes how oversight gets done day to day.
What’s the Catch?
WiseCLIN is clearly built for a specific type of organization, so it’s a good idea to understand upfront who it suits best.
- It is built specifically for RBQM not general clinical trial management. Organizations looking for an all in one clinical trial platform with RBQM as a minor feature might find WiseCLIN’s focus narrower than expected as it’s designed to specialise rather than generalise.
- Getting full value likely means engaging with training. Given how configurable the platform is, teams that skip the consulting and training support from Pharmity might not see the full benefit straight away.
Neither is really a downside as such but worth knowing before you commit.
Final Verdict
WiseCLIN offers a valuable structured alternative backed by a team with real clinical quality and technical development credentials. Between its compliance-first design, configurable feature set and the added support from Pharmity, Qlarix has built something that looks less like another dashboard and more like a serious answer to an industry wide problem.
